Clinical Trial Update: A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating drug-drug interaction between RO5503781 and posaconazole, oral formulation bioavailability of RO5503781, and the food effect on RO55037…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)
• RO5503781

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED